Laboratory tests and complementary studies |
Laboratory tests and complementary studies |
Laboratory tests and complementary studies |
Laboratory tests and complementary studies |
Laboratory tests and complementary studies |
Laboratory tests and complementary studies |
Hemoglobin (g/L) [mean (SD)] |
11.98 (2.09) |
0 (0%) |
10.6 (1.4) |
13.8 (1.3) |
<0.001 |
Hematocrit (%)[mean (SD)] |
37 (6) |
253 (1.9%) |
33 (4) |
42 (4) |
<0.001 |
EDW (%)[mean (SD)] |
18 (15) |
4347 (32%) |
18.9 (16.7) |
16.8
(12.2) |
<0.001 |
EDW > 16.5% [n (%)] |
3137 (34.4) |
4347 (32%) |
2261 (43.2) |
876 (22.6) |
<0.001 |
Leukocytes (elements /mm3) [media (SD)] |
9427 (6882) |
1531
(11.4%) |
9271 (7277) |
9611 (6297) |
0.007 |
Platelets (elements /1000/L) [mean (SD)] |
229.3 (127.0) |
2296
(17.1%) |
237 (133) |
219 (119) |
<0.001 |
Mean platelet volume (fl) [mean (SD)] |
10.2 (11.7) |
3835 (28.5%) |
10.1 (7.6) |
10.2 (14.9) |
0.56 |
Glucose (mg/dl) [mean (SD)] |
149 (84) |
1572 (11.7) |
151 (86) |
146 (80) |
0.004 |
Urea (mg/dl) [mean (SD)] |
66.8 (48.3) |
942 (7%) |
73.8 (52.2) |
57.3 (40.2) |
<0.001 |
Cre atinine (mg/dl) [mean (SD)] |
1.36 (0.85) |
0 (0%) |
1.50
(0.96) |
1.16 (0.61) |
<0.001 |
eGFR < 60 ml/min/1.73 m2 [n(%)] |
8250 (63.6) |
478
(3.6%) |
5269 (70.9) |
2981 (53.8) |
<0.001 |
Sodium < 135 mEq/l [n(%)] |
2437 (18.5) |
284 (2.1%) |
1523 (20.3) |
914 (16.1) |
<0.001 |
NTproBNP (mg/dl) [mean (SD)] |
3918 (55.1) |
7733 (57.5%) |
8472
(13676) |
6812 (13093) |
<0.001 |
Positive troponins [n (%)] |
7769 (13431) |
6349 (47.2%) |
2296
(58.4) |
1622 (51.1) |
<0.001 |
Atrial fibrillation in the ECG [n(%)] |
5918 (48.6) |
1281 (9.5%) |
3232 (46.5) |
2685 (51.4) |
<0.001 |
Emergency department treatment and management |
Emergency department treatment and management |
Emergency department treatment and management |
Emergency department treatment and management |
Emergency department treatment and management |
Emergency department treatment and management |
Conventional oxygen therapy [n(%)] |
9767 (73.4) |
145 (1.1%) |
5647 (74.5) |
4120 (71.9) |
0.001 |
Bolus of loop diuretics [n(%)] |
10762 (80.9) |
143 (1.1%) |
6187
(81.6) |
4575 (79.9) |
0.01 |
Continuous intravenous perfusion of loop diuretics [n(%)] |
611
(4.6) |
145 (1.1%) |
353 (4.7) |
258 (4.5) |
0.68 |
Intravenous nitrates [n(%)] |
2064 (15.5) |
143 (1.1%) |
1195
(15.8) |
869 (15.2) |
0.35 |
Digoxin [n(%)] |
1881 (14.1) |
144 (1.1%) |
884 (11.7) |
997
(17.4) |
<0.001 |
Morphine [n(%)] |
681 (6.1) |
2315 (17.2%) |
382 (6) |
299 (6.2) |
0.62 |
Stay in Observation Unit [n(%)] |
3810 (30.3) |
883 (5.6%) |
2252
(31.3) |
1558 (28.9) |
0.004 |
Hospital admission [n(%)] |
10117 (75.2) |
9 (0.07%) |
5849 (76.4) |
4268 (73.7) |
<0.001 |
Follow-up |
Follow-up |
Follow-up |
Follow-up |
Follow-up |
Follow-up |
In-hospital mortality [n(%)] |
1002 (7.5) |
51 (0.4%) |
648 (8.5) |
354 (6.1) |
<0.001 |
Mortality at 30 days [n(%)] |
1245 (9.3) |
93 (0.69%) |
816 (10.7) |
429 (7.5) |
<0.001 |
Mortality at 180 days [n(%)] |
2755 (20.6) |
93 (0.69%) |
1791
(23.5) |
964 (16.8) |
<0.001 |
Mortality at one year [n(%)] |
3611 (27) |
93 (0.69%) |
2394
(31.4) |
1217 (21.2) |
<0.001 |
Reconsultation to the ED [n (%)] |
4254 (35.2) |
1694 (12.3%) |
2574 (37.8) |
1680 (31.7) |
<0.001 |